News

Children who have previously experienced alloimmunization may be at increased risk of complications during stem cell transplants.

Few studies have reported on alloimmunization against the Kpa antigen, a rare cause of HDFN.

Transplacental intrauterine transfusion, a treatment used in HDFN, may increase antibody levels, particularly in those with anterior placenta.

Standard hemoglobin screening may miss iron deficiency that could affect maternal health and newborn blood outcomes, including HDFN.

Most of the family planning providers surveyed no longer conduct Rh testing or give Rh immunoglobulin for HDFN before 12 weeks of pregnancy.

Around the world, more babies are being diagnosed with newborn jaundice, but fewer babies are dying or becoming seriously disabled from it.

While many babies recover and blood levels usually return to normal by one year of age, HDFN can still lead to serious complications.

A case of HDFN caused by anti-Jkb antibody highlights the need for detailed blood tests in infants with unexplained jaundice.

Modern HDFN therapies are largely effective, but global treatment access is not uniform.

Some patients who received a blood-filtering treatment were able to wait until they were further along in their pregnancies to begin IUTs.